Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialSystematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastasesResection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomesHepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancerStrategies to increase the resectability of hepatocellular carcinomaA multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literatureOligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsSystematic review: brain metastases from colorectal cancer--Incidence and patient characteristicsUnresolved issues and controversies surrounding the management of colorectal cancer liver metastasisRecurrence after operative management of intrahepatic cholangiocarcinomaIdentification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths.Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survivalPrognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis.18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?Effect of M1a and M1b category in metastatic colorectal cancer.Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyTwo-stage strategy for patients with extensive bilateral colorectal liver metastases.A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastasesSurgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastasesStrategies for Management of Synchronous Colorectal Metastases.National trends in discharge disposition after hepatic resection for malignancyInhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon SystemSynchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges.Colorectal hepatic metastasis: Evolving therapies.Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases.Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX sIncidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesThe role of peri-operative treatment in resectable liver metastases of colorectal cancer.The role of microRNA-200 in progression of human colorectal and breast cancer.Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumorsSarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer.Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging?
P2860
Q21261279-F1A75776-225F-4187-8CF9-2E5C7154031CQ26744398-E9397921-E0D0-421D-A748-76DCB9C3E5AFQ26750691-BC4A261E-C1AE-4758-9165-71667128BB63Q26772267-256914FF-AC5C-436D-B2E6-CD56E8027B54Q26795530-A4C7165C-468D-4C04-9CF4-A8D7586E79F8Q26800770-8D08E6CB-9FEF-4B4B-AC38-B7EB0A73A9B9Q27334649-06779BD2-244C-478D-BE9D-812F1B296DA6Q28066158-1A55D6CB-DAA1-4BC3-8EC6-6CFFC5B289EDQ28085651-8A2C8A42-BA54-455D-9BDE-CAF407C5A112Q30412886-80432E99-A432-463A-84D0-89A2A78C9BCEQ33578266-6D9725B3-3117-4487-A7E1-807621C535FFQ33645438-64AE57E1-9B08-49CA-A02C-FC62B210B02AQ33656676-03545A9C-2036-4A69-8C41-9761A8BE84BBQ33695043-02C5AB4C-A4C9-433D-AA37-364ED6FF018DQ33720763-634DA86A-09EE-4106-8E54-DEE07E28E03DQ33720942-ABF27FB8-584A-4967-A46C-E9E8D2D2558EQ33776697-F1A1B215-E1B4-4081-8A06-E556FCCA92E0Q33829754-B2AD61A1-B605-41FC-939E-9C98279ED8DBQ33850248-376F9609-CC07-421D-975E-40991D546428Q33865026-B4D153CD-957F-4B50-8EFC-A4CA21833AC9Q33994298-6608755B-9079-45C0-8C57-3F332A94D4A7Q34003713-93A3073B-1A55-49EC-8EEF-618CC795721DQ34013522-A71EF99A-21E3-473D-B006-211FDAD0FA12Q34207776-3FBA9A7F-298C-4164-B72B-93B6B754031AQ34294365-8967D528-B3E4-4AF5-9C1A-9B97B588599FQ34490042-9DB0BA9A-CF31-4F18-8A1D-12A1D8AAC33FQ34572707-1FF203BC-058B-49F4-BEBD-3DE82163C721Q34602250-A022F434-9FD1-4C9F-A44B-CC9E4E8376C1Q34608072-944415C2-5069-4458-902E-571B76727D6AQ34618754-1B654F9A-BE6B-46B0-A21F-86F8D6832FEAQ34663557-933590B2-B457-4630-A0EA-E1DF6A6A0C22Q34747786-A38DDCAF-15AA-48B2-B9FA-0B9C7EC309F4Q34894115-694B2A1F-46F5-4AC3-975E-09DF308FC630Q35012020-9EC05817-A7AA-4E69-9147-54215D75325BQ35076305-FB749E00-21A3-4012-9B5B-38D44865BCA6Q35078489-6DC0CD2C-B338-4156-9504-94CEB1449D71Q35096126-776B487D-3F83-46AC-B65F-3AFF39F84639Q35097594-E6EBA550-FD61-45CC-BAF9-6A7107153FA7Q35195285-04CC194F-F2BD-465E-8747-A13140ADC48FQ35244248-A56DAE8D-42BC-4C1E-99B3-86C1ADF84433
P2860
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@en
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@nl
type
label
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@en
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@nl
prefLabel
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@en
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@nl
P2093
P1433
P1476
Rates and patterns of recurren ...... nal analysis of 1669 patients.
@en
P2093
Carlo Pulitano
Dario Ribero
Gilles Mentha
Jennifer Strub
Lorenzo Capussotti
Luca Aldrighetti
Mechteld C de Jong
Michael A Choti
Richard D Schulick
P304
P356
10.1097/SLA.0B013E3181B4539B
P407
P577
2009-09-01T00:00:00Z